Clinical Trial Update: Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether post-operative chemotherapy benefits patients with localized uterine leiomyosarcoma assessed as high-risk of recurrence by a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Snippet

Sponsor: UNICANCER | Conditions: Leiomyosarcoma Uterus | Phase 2 | Status: RECRUITING